Welcome: Guest | Site Use Options | Register | Login |

Fairbanks Pharmaceuticals

Fairbanks Pharmaceuticals

Profile last edited on: 9/30/2019
158 Laurel Street
Concord, MA 01742
  (617) 922-5384
Business Identifier: Tackling diabetes through beta cell repair and regeneration
Public Profile:
With a focus on understanding the underlying caused of the disease - ss of insulin from beta cells - not just the symptoms, Fairbanks Pharmaceuticals is developing novel treatments for diabetes. Efforts of the firm organzie around facilitating repair of existing insulin-producing beta cells in the short term and regeneration of new beta cells in the longer term. In October 2018, the firm was awarded the 2018 Boston Innovation Prize by Boehringer Ingelheim which included a golden ticket to LabCentral.

 Synopsis: Awardee Business Condition
Year Founded First SBIR Year Date of Last Award
Employee Range VC funded? IP Holdings
Revenue Range Private/Public Exchange/Symbol :
 Most Recent SBIR Projects
Year Phase Agency Dollars Project Title
Development of Novel Diabetes Therapies Based on Neutralizing FSTL3 Activity

Unlock access

To unlock access to all SBIR-STTR company Profiles, a FREE site registration is required. Click here to register or login if you already have an account

Smart Office Options

SBIR firms in the news


Is this YOUR Company?

Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached

Do you know about this Awardees?

Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Contact information

Innovation Development Institute, LLC

   45 Beach Bluff Avenue, Suite 300
     Swampscott,  MA 01907-1542

  Tel:  (781) 595-2920